Giovanni Mambrini

Giovanni Mambrini has a diverse work experience spanning over two decades. Giovanni is currently the Chief Technology Officer at Quince Therapeutics, a position they have held since October 2023. Prior to this role, they served as the Chief Operating Officer at EryDel S.p.A. from June 2012 to October 2023. During their time at EryDel S.p.A., they also held the position of General Manager and co-founder from October 2008 to July 2018. Before joining EryDel S.p.A., Giovanni worked at Sorin Group as the Biocompatibility and Biosensors Discipline Leader from April 2002 to September 2008. Giovanni started their career at Covidien in a research and development role from 1998 to 2002.

Giovanni Mambrini received their PhD in Pharmaceutical Chemistry from Bologna Alma Mater Studiorum, where they studied from 1991 to 1996.